|
⚲
|
| Keyboard |
| Nussbaum Ran
✚
|
|
|---|---|
| CIK # | 0001609805 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001609805] | |
| 4 | [0001609805] | |
| SC 13G | [0001609805] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Keros Therapeutics Inc KROS
Common Stock, $0.0001 par value per share
|
2025-10-15 | Sell | 2,284,612 | $17.75 | 40,551,863 |
|
Keros Therapeutics Inc KROS
Common Stock, $0.0001 par value per share
|
2025-10-15 | Sell | 155,262 | $17.75 | 2,755,900 |
|
Keros Therapeutics Inc KROS
Common Stock, $0.0001 par value per share
|
2025-10-15 | Sell | 1,226,412 | $17.75 | 21,768,813 |
|
Keros Therapeutics Inc KROS
Common Stock, $0.0001 par value per share
|
2025-10-15 | Sell | 1,121,045 | $17.75 | 19,898,549 |
|
Keros Therapeutics Inc KROS
Common Stock
|
2025-06-04 | Grant | 5,250 | $0.00 | |
|
Keros Therapeutics Inc KROS
Stock Option (right to buy) · derivative
|
2025-06-04 | Grant | 10,500 | $0.00 | |
|
Keros Therapeutics Inc KROS
Stock Option (right to buy) · derivative
|
2024-05-30 | Grant | 10,000 | $0.00 | |
|
Keros Therapeutics Inc KROS
Stock Option (right to buy) · derivative
|
2023-06-06 | Grant | 10,000 | $0.00 | |
|
Keros Therapeutics Inc KROS
Call Options (obligation to sell) · derivative
|
2022-11-29 | Option exercise | 1,723 | $0.00 | |
|
Keros Therapeutics Inc KROS
Call Options (obligation to sell) · derivative
|
2022-11-29 | Option exercise | 3,539 | $0.00 | |
|
Keros Therapeutics Inc KROS
Common Stock
|
2022-11-29 | Option exercise | 3,539 | $0.00 | |
|
Keros Therapeutics Inc KROS
Common Stock
|
2022-11-29 | Option exercise | 1,914 | $0.00 | |
|
Keros Therapeutics Inc KROS
Common Stock
|
2022-11-29 | Option exercise | 1,723 | $0.00 | |
|
Keros Therapeutics Inc KROS
Call Options (obligation to sell) · derivative
|
2022-11-29 | Option exercise | 1,914 | $0.00 | |
|
UroGen Pharma Ltd URGN
Stock Option (right to buy) · derivative
|
2022-10-21 | Option exercise | 32,723 | $0.00 | |
|
UroGen Pharma Ltd URGN
Ordinary Shares
|
2022-10-21 | Option exercise | 47,999 | $5.94 | 285,114 |
|
UroGen Pharma Ltd URGN
Stock Option (right to buy) · derivative
|
2022-10-21 | Option exercise | 15,276 | $0.00 | |
|
UroGen Pharma Ltd URGN
Ordinary Shares
|
2022-06-16 | Option exercise | 2,211 | $5.00 | 11,055 |
|
UroGen Pharma Ltd URGN
Stock Option (right to buy) · derivative
|
2022-06-16 | Option exercise | 2,211 | $0.00 | |
|
Senesco Technologies Inc ELOX
Stock Options (Right to Buy) · derivative
|
2022-06-15 | Grant | 20,000 | $0.00 | |
| showing 20 of 163 most recent transactions | |||||